Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR: Best practices in global flow cytometry quality control and harmonization 3 days 8 hours 1 mins 49 secs REGISTER NOW

Infographic: trends in LBA

3 Sep 2019
General interest

As part of our Spotlight on LBA, we carried out a survey to gain an insight into the trends, challenges and developments associated with this technique. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

LBA spotlight infographic

Top content

  • Gilead to buy Arcellx for up to $7.8 billion
  • Can we predict Alzheimer’s years in advance?
  • Advancing HIV research and equity: Dionna’s unique path in science

Related tags

infographic ligand-binding assay
Previous article Next article

Related articles

" A grid pattern of blue test tubes overlapped by a single purple antibody."
20 JAN 2025 INTERVIEWS
60-seconds with Francis Dessy & Ivo Sonderegger: Harmonization of vaccine ligand binding assays validation
2 OCT 2018 TOXICOLOGY
Top 5 tips: utilizing alternative matrices
17 FEB 2025 JOURNAL ARTICLES
Cross-validation of pharmacokinetic assays post-ICH M10 is not a pass/fail criterion
27 JUN 2025 EXPERT OPINION
Mastering bioanalytical project management
19 JUN 2019 GENERAL INTEREST
How to get it right the first time: the feasibility of singlet analysis for ligand binding assays
14 DEC 2021 LBA
Poster: polyclonal solution for next generation multispecific antibody therapeutics
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone